Reply to: A Daunting and Challenging Task to Prove the Effectiveness of Reducing Acute Exacerbation in COPD Patients with Type 2 Diabetes by GLP-1 Receptor Agonists.
Dinah FoerZachary H StrasserJing CuiKatherine N CahillJoshua A BoyceShawn N MurphyElizabeth W KarlsonPublished in: American journal of respiratory and critical care medicine (2023)